Xeris Biopharma Holdings
XERS
XERS
120 hedge funds and large institutions have $144M invested in Xeris Biopharma Holdings in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 31
9% more funds holding
Funds holding: 110 → 120 (+10)
4.42% more ownership
Funds ownership: 39.85% → 44.27% (+4.4%)
Holders
120
Holding in Top 10
3
Calls
$1.95M
Puts
$190K
Top Buyers
| 1 | +$4.24M | |
| 2 | +$1.5M | |
| 3 | +$1.34M | |
| 4 |
DMKJ
David M. Knott Jr
|
+$912K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$873K |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$1.22M | |
| 3 | -$725K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$676K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$603K |